C D4 and CD8 T cells contribute to immunity through cytolytic activity and by secretion of cytokines. Cytolytic activity requires direct recognition of an infected cell and formation of an immunological synapse, the site of Ag-specific CTL activation, as well as the site of delivery of cytolytic effector molecules that kill the target cell (1, 2). Cytokine-secreting CD4 and CD8 T cells also require activation through immunological synapses, followed by vectorial or multidirectional release of cytokines (3) . Secreted cytokines may act directly on the infected cell bearing the peptide-MHC complexes that provide the signal for T cell activation (3, 4), or they may diffuse within a tissue to activate "bystander" cells, which were not involved in engaging and activating Ag-specific T cells (5, 6) . A recent study reported that Leishmania major, an intracellular pathogen of macrophages and dendritic cells (DC), can be controlled by bystander activation of Ag-specific CD4 T cells through secretion and diffusion of IFN-g, which caused killing of intracellular L. major up to 80 mm from the activated T cell (5) .
Mycobacterium tuberculosis is also an intracellular pathogen of macrophages and DC, and it requires CD4 T cells and IFN-g to restrict its growth and dissemination (7). Unlike L. major, M. tuberculosis can persist and cause disease with high pathogen burdens, despite the expansion, differentiation, and trafficking of CD4 T cells to the site of infection (8) . However, it remains unclear precisely how CD4 T cells contribute to the control of M. tuberculosis (9) . In mice, administration of Th1-polarized TCRtransgenic CD4 T cells specific for the M. tuberculosis Ag, ESAT-6, provides potent antimycobacterial effects (10), yet these effects are independent of the ability of the transferred T cells to produce either IFN-g or TNF (11) . Similarly, reconstitution of RAG2 mice by transfer of CD4 memory T cells from mice previously infected with M. tuberculosis conferred comparable control of subsequent infection, whether the transferred T cells were competent to produce IFN-g or not (12) .
In humans, the mechanisms used by CD4 T cells to control the progression of M. tuberculosis are similarly poorly understood. In a recent clinical trial of bacillus Calmette-Guérin vaccination, infants that were protected from tuberculosis (TB) did not differ with regard to their mycobacterial Aginduced CD4 or CD8 T cell secretion of IFN-g, TNF, IL-2, or IL-17 from infants that developed TB (13) . Likewise, adults can exhibit Ag-specific polyfunctional CD4 and CD8 T cell responses, yet still progress to active TB (14) (15) (16) . Therefore, although CD4 T cells are essential for immunity to M. tuberculosis, the effector mechanisms that they use to control M. tuberculosis are incompletely defined.
To further understand the contributions of CD4 T cells to immunity in TB, we determined whether immune control of M. tuberculosis requires direct recognition of infected cells or whether bystander activation of CD4 effector cells is sufficient to restrict infection.
Materials and Methods
Generation and infection of MHC class II mixed bone marrowchimeric mice and CD4 T cell depletion Mixed bone marrow chimeras were generated as described (17) bone marrow cells. Chimeras were infected 7 wk later by aerosol (∼100 CFU/ mouse) with M. tuberculosis H37Rv that expresses FACS-optimized GFP (18, 19) . Selected animals were treated every 5 d with 500 mg CD4-depleting Ab (GK1.5) or isotype control (LTF-2), starting at 18 d postinfection and continuing until the day of harvest (day 35). Single-cell intracellular bacterial burdens were determined in sorted GFP + cell subsets by fluorescence microscopy and manual counting. Bacterial loads in lung homogenates and sorted cell populations were determined by plating serial dilutions on 7H11 agar. Procedures involving mice were approved by the New York University School of Medicine Institutional Animal Care and Use Committee.
Cell sorting
Lung cells from MHC II mixed chimeras infected with M. tuberculosis H37Rv-GFP were stained with CD11c, CD11b, and Gr-1 Abs, as described (19, 20) . Following staining, samples were pooled (two to four mice/pool; three pools/ group), and live cells were sorted using an iCyt Synergy sorter in BSL-3 containment into MHC II +/+ and MHC II 2/2 CD11c hi CD11b hi DC and CD11c lo/int CD11b med recruited macrophages (RM). GFP + cells were sorted from each of the DC and RM subsets and either fixed for microscopic determination of single-cell bacterial burdens or plated for quantitation of live bacteria.
Statistical analysis
Statistical comparisons were performed with Prism 4 for Macintosh (GraphPad, San Diego, CA), using the tests specified in the figure legends. The p values , 0.05 were considered significant.
Results and Discussion
To determine whether direct recognition of infected cells by CD4 effector T cells is required for optimal control of M. tuberculosis, we prepared mixed bone marrow-chimeric mice using equal numbers of cells from MHC II +/+ (CD45.1) and MHC II 2/2 (CD45.2) mice and infected them with M. tuberculosis that expresses FACS-optimized GFP (17) (18) (19) . This allows assessment of the number of infected cells and the number of bacteria associated with cells that can (MHC II +/+ ) or cannot (MHC II 2/2 ) be directly recognized by CD4 T cells, after isolation from the same lung environment.
Following infection with M. tuberculosis, mice reconstituted with 50% MHC II +/+ and 50% MHC II 2/2 bone marrow responded with equivalent (by frequency; Fig. 1A (Fig. 1C) , consistent with less effector T cell activation in the lungs. Concordant with the evidence of less effector T cell activation, the II +/+ :II 2/2 mice had 5-fold more bacteria in the lungs on day 35 postinfection (Fig. 1D) .
To determine whether the higher bacterial burdens in the lungs of II (19) . This revealed that 8-11% of the cells in each subset contained bacteria, as determined by flow cytometry after isolation from the lungs of mixed chimeras (Fig. 2) ; this did not differ significantly by the presence or absence of MHC II in either subset (DC: II +/+ 9.1 6 0.8, II 2/2 10.8 6 0.9, p = 0.4; RM: II +/+ 8.2 6 0.5, II 2/2 11 6 1.1, p = 0.1). These results indicate that the absence of MHC II expression on lung DC or RM has little or no effect on the proportion of cells that contain bacteria.
As an alternative explanation for the larger bacterial burden in the lungs of II +/+ :II 2/2 mixed chimeras, we determined whether the absence of MHC II expression resulted in poorer control of infection manifest as a larger number of bacteria/ infected cell. We sorted lung cells from M. tuberculosis-GFPinfected MHC II mixed chimeras on the basis of cell phenotype (DC or RM), the presence or absence of the ability to express MHC II (using CD45.1 + to identify MHC II +/+ and CD45.1 2 to identify MHC II 2/2 cells [from CD45.2 donors]), and the presence of GFP fluorescence. The number of bacteria/cell in GFP + DC and RM was then quantitated by fluorescence microscopy. This revealed that the number of bacteria/infected DC (Fig. 3A) or RM (Fig. 3B) ) were gated out before sorting cells into CD11c/CD11b subsets. The fluorescence of the same cell subsets from mice infected with the parental strain of M. tuberculosis H37Rv that does not express GFP is also shown (far right panels). Data were obtained by preparing triplicate pools prior to sorting, with each pool containing cells from two to four mice. Comparable results were obtained in three independent experiments. *p , 0.05, **p , 0.01, ***p , 0.001, Student t test and Mann-Whitney U test. bacteria. Using the same sorting parameters as described for quantitating bacteria/infected cell by microscopy, we quantitated live bacteria (as CFU)/1000 GFP + cells in each sorted fraction. This revealed that the number of live M. tuberculosis is greater in MHC II 2/2 DC and RM compared with MHC II +/+ DC and RM in CD4 T cell-replete mice (Fig. 3C, 3D ). Depletion of CD4 T cells resulted in significant increases in the number of live bacteria associated with MHC II +/+ DC and RM, confirming that CD4 T cells contribute to the control of intracellular M. tuberculosis by restricting the number of bacteria/infected cell. In contrast, CD4 T cell depletion had no effect on the number of live bacteria associated with MHC II 2/2 DC or RM (Fig. 3C, 3D ). This indicates that CD4 T cell control of intracellular M. tuberculosis depends on direct recognition of infected cells and that this mechanism predominates over those that can occur as the consequence of bystander activation, such as through the action of diffusible cytokines.
The requirement for direct recognition of infected lung myeloid cells by CD4 effector T cells for optimal control of M. tuberculosis is clearly distinct from findings with regard to L. major, in which bystander activation of CD4 effector cells is sufficient for control of intracellular parasites (5) . There are three possible explanations for the differences in the results with L. major and M. tuberculosis. One is that infection with M. tuberculosis establishes a tissue environment in which diffusion of cytokines secreted by activated CD4 effector cells is restricted, thereby preventing secreted cytokines from acting on infected cells at a distance. For example, IFN-g binds to glycosaminoglycans, restricting the diffusion and the action of IFN-g (22) , and glycosaminoglycans are deposited in high concentrations at the site of infection in TB (23) . Related to this, another possibility is that the amount of IFN-g produced per CD4 effector cell is low in TB, and this restricts its effects to adjacent cells. The other potential explanation for the requirement for direct CD4 T cell recognition of M. tuberculosis-infected cells in vivo is that control of M. tuberculosis requires the action of one or more mechanisms that requires direct contact between CD4 effector cells and M. tuberculosisinfected cells. This is consistent with the recent observations that CD4 T cells contribute to the control of M. tuberculosis in vivo, even when they are not competent to secrete IFN-g or TNF, express perforin, or interact with Fas (11, 12) . Our results suggest that further investigation of CD4 effector mechanisms in TB must concentrate on mechanisms that require direct recognition and contact with infected cells.
Our results have implications for TB vaccine development. First, these results suggest that TB vaccines that promote the development of CD4 T cell mechanisms that operate through direct recognition and contact of infected cells may have greater efficacy than do vaccines that induce polyfunctional cytokine responses alone. Therefore, investigation of vaccine vectors and adjuvants should include the determination of their ability to induce T cells with effector mechanisms that extend beyond cytokine secretion. Second, considering recent evidence that the frequency of Ag-specific CD4 effector T cell activation at the site of infection is low (4, 24) and that this limits the antimycobacterial efficacy of Ag-specific CD4 effector T cells (24) , the results reported in this article indicate the need for better understanding of the mechanisms of Ag presentation and their limitations in cells infected with M.
tuberculosis. In light of evidence that M. tuberculosis interferes with MHC II Ag presentation by the cells that it infects (25) (26) (27) (28) (29) (30) , vaccine-induced CD4 T cells may have limited efficacy unless the mechanism(s) that limit Ag presentation can be overcome or bypassed. The evidence that optimal control of intracellular M. tuberculosis requires direct recognition of infected cells by CD4 effector T cells heightens the importance of identifying the mechanisms that attenuate MHC II Ag presentation in M. tuberculosis-infected cells.
